Other studies have mainly paid close attention to the prognostic value of TIL subsets, such as CD3+, CD4+, CD8+, CD20+ and FoxP3+ lymphocyte subsets in the TN and/or TS of NSCLC. This evidence concerns the gene CD4 and non-small cell lung carcinoma.